The LancetSafety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialJan 24, 2022More
Phys.orgSARS-CoV-2 spike protein activates human endogenous retroviruses in blood cellsJan 24, 2022More
Full Coverage